Finance

Lists
600079:SHA
Humanwell Healthcare (Group) Co Ltd
CNÂ¥19.23
+0.26%
(+0.050) 1D
Oct 9, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600079...
Open
CNÂ¥19.19
High
CNÂ¥19.32
Low
CNÂ¥19.01
Mkt. cap
31.31B
Avg. vol.
8.03M
Volume
10.81M
Dividend
2.50%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Aug 3, 2026
P/E ratio
15.45
52-wk high
CNÂ¥21.76
52-wk low
CNÂ¥16.03
EPS
CNÂ¥1.25
Shares outstanding
1.35B
No. of employees
17K
Open
CNÂ¥19.19
High
CNÂ¥19.32
Low
CNÂ¥19.01
Mkt. cap
31.31B
Avg. vol.
8.03M
Volume
10.81M
Dividend
2.50%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Aug 3, 2026
P/E ratio
15.45
52-wk high
CNÂ¥21.76
52-wk low
CNÂ¥16.03
EPS
CNÂ¥1.25
Shares outstanding
1.35B
No. of employees
17K
News stories
From web sources and news partners
About Humanwell Healthcare (Group) Co Ltd
CEO-
Employees17.2K
Founded1988
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.82B
6.08B
6.10B
5.96B
Cost of goods sold
3.05B
3.13B
3.08B
2.93B
Cost of revenue
3.05B
3.13B
3.08B
2.93B
Research and development expenses
307.03M
450.29M
358.60M
281.36M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.47B
1.66B
1.62B
1.53B
Operating expense
1.77B
2.26B
2.00B
1.88B
Total operating expenses
4.82B
5.38B
5.08B
4.81B
Operating income
1.00B
697.65M
1.02B
1.15B
Other non operating income
-41.92M
30.53M
-57.02M
11.34M
EBT including unusual items
842.44M
424.80M
940.21M
1.06B
EBT excluding unusual items
877.19M
691.55M
944.61M
1.02B
Income tax expense
156.49M
115.47M
170.15M
134.66M
Effective tax rate
18.58%
27.18%
18.10%
12.75%
Other operating expenses
-41.31M
142.86M
2.12M
108.74M
Net income
533.91M
166.76M
588.17M
741.39M
Net profit margin
9.17%
2.74%
9.64%
12.44%
Earnings per share
-
0.06
0.34
0.45
Interest and investment income
8.70M
50.84M
31.56M
12.80M
Interest expense
-59.54M
-56.55M
-52.91M
-56.12M
Net interest expenses
-50.84M
-5.71M
-21.35M
-43.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.22B
943.31M
1.27B
1.36B
Gain or loss from assets sale
-351.25K
-55.57M
-
-2.51M
AI content may include mistakes. Learn more
Google apps